ArriVent BioPharma, Inc. Common Stock

AVBP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.4B

Short interest (May 15)

15.7%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.60%

↓ 1.6%

Available Shares

↑ 122.1%

Price Chart

Company Overview

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001868279

Asset Type: CS

Market Data

Market Cap: $1,393,521,845

Employees: 77

Status: Active

Short Interest

Current Borrow Fee 0.60%

Range: 0.60% - 0.65%

Available Shares 3M

Range: 2.7M - 3.1M

Recent Changes

Fee Change: ↓ 0.6%

Available Change: ↑ 5.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime